Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep;35(3):312-319.
doi: 10.1053/j.semvascsurg.2022.06.002. Epub 2022 Jul 4.

Fenestrated and branched stent grafts for the treatment of post-dissection thoracoabdominal aortic aneurysms

Affiliations
Review

Fenestrated and branched stent grafts for the treatment of post-dissection thoracoabdominal aortic aneurysms

Pablo Marques de Marino et al. Semin Vasc Surg. 2022 Sep.

Abstract

The present study aims to analyze fenestrated/branched endovascular aneurysm repair (F/BEVAR) in the treatment of post-dissection thoracoabdominal aortic aneurysms (PD-TAAAs). Focus is given on indication, anatomic suitability, device planning, and clinical outcomes. PD-TAAAs present with additional challenges in F/BEVAR. These include true lumen compression and visceral arteries originating from the false lumen. These technical challenges limited the use of F/BEVAR in PD-TAAAs to a few institutions in the beginning, but the good results reported with this approach have led to an increase in its use in a growing number of centers. Our current single-center experience includes 75 patients treated with F/BEVAR for a PD-TAAA between October 2010 and October 2021. Technical success was achieved in 74 cases (98.7%). Two patients (2.6%) died in the first 30 postoperative days. Ten patients (13.3%) had postoperative symptoms of spinal cord ischemia: 9 (12%) with transient limb weakness and 1 (1.3%) with permanent paraplegia. There was only 1 death (1.3%) related to the aneurysm during follow-up. Mean ± SD estimated primary patency rates of the target vessels at 12, 24, and 36 months were 97.9% ± 1%, 96.1% ± 1.6%, and 95.2% ± 1.9%, respectively. The estimated freedom from re-intervention rates at these time points were 81.4% ± 5.3%, 56.9% ± 7.3%, and 53.9% ± 7.5%, respectively. In conclusion, F/BEVAR can be performed in PD-TAAAs with high rates of technical success and good mid-term results with regard to mortality and morbidity. The additional technical challenges posed by PD-TAAAs need to be considered to prevent complications and decrease the high rate of re-interventions.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The declaration of interest has been included before as it follows: Eric L. Verhoeven has received research grants from Cook Inc, and honoraria as speaker and consultant from Cook Inc, W.L. Gore & Associates, Maquet-Getinge, Bentley InnoMed, and Siemens Healthineers. Athanasios Katsargyris has received honoraria as speaker for Cook Inc.

MeSH terms

LinkOut - more resources